Literature DB >> 10398253

Cytogenetic and molecular evidence for cutaneous mosaicism: the ectodermal origin of Blaschko lines.

C Moss1.   

Abstract

The idea that skin disorders following Blaschko lines represent genetic mosaicism is widely accepted. It seems likely that the two skin types represent the two different genotypes, but this has been remarkably difficult to prove, most studies showing a mixture of cell types in biopsies from both types of skin. Only for linear epidermolytic hyperkeratosis has it been possible to show mutant cells confined to the abnormal streaks. The hypothesis proposed here to explain this paradox is that disorders following Blaschko lines are due to mutations in genes expressed in epidermal cells (keratinocytes and melanocytes) rather than in dermal fibroblasts. The work on epidermolytic hyperkeratosis used keratinocytes, whereas most studies have used skin fibroblasts. Almost all disorders following Blaschko lines are epidermal: inflammatory, dysplastic, dyskeratotic, appendage-related, or pigmentary, and the remainder can be explained on the basis of epidermal influences on the dermis. If this hypothesis is correct, it points to a useful model system for elucidating the genetic component of common dermatoses sometimes found in Blaschko lines namely eczema, psoriasis, lichen planus, and vitiligo. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10398253     DOI: 10.1002/(sici)1096-8628(19990806)85:4<330::aid-ajmg3>3.0.co;2-m

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  7 in total

1.  Diagnostic evaluation for asymmetry: consider genetic mosaicism.

Authors:  Koen Devriendt; Jean-Pierre Fryns
Journal:  Eur J Pediatr       Date:  2004-10       Impact factor: 3.183

2.  Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome.

Authors:  Jared J Barrott; Gabriela M Cash; Aaron P Smith; Jeffery R Barrow; L Charles Murtaugh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

3.  Incontinentia pigmenti: clinical observation of 40 Korean cases.

Authors:  Beom Joon Kim; Hyo Seung Shin; Chong Hyun Won; Jong Hee Lee; Kyu Han Kim; Myeung Nam Kim; Byung In Ro; Oh Sang Kwon
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

Review 4.  Pigmentary mosaicism: a review of original literature and recommendations for future handling.

Authors:  Anna Boye Kromann; Lilian Bomme Ousager; Inas Kamal Mohammad Ali; Nurcan Aydemir; Anette Bygum
Journal:  Orphanet J Rare Dis       Date:  2018-03-05       Impact factor: 4.123

5.  Genetic and clinical characterization of 73 Pigmentary Mosaicism patients: revealing the genetic basis of clinical manifestations.

Authors:  C Salas-Labadía; S Gómez-Carmona; R Cruz-Alcívar; D Martínez-Anaya; V Del Castillo-Ruiz; C Durán-McKinster; V Ulloa-Avilés; E Yokoyama-Rebollar; A Ruiz-Herrera; P Navarrete-Meneses; E Lieberman-Hernández; A González-Del Angel; D Cervantes-Barragán; C Villarroel-Cortés; A Reyes-León; D Suárez-Pérez; A Pedraza-Meléndez; A González-Orsuna; P Pérez-Vera
Journal:  Orphanet J Rare Dis       Date:  2019-11-15       Impact factor: 4.123

6.  Compound-honeysuckle-induced drug eruption with special manifestations: A case report.

Authors:  Li-Feng Zhou; Rong Lu
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

7.  Congenital epidermal nevus.

Authors:  Bhawna Arora; Vineet Inder Singh Khinda; Nitika Bajaj; Gurlal Singh Brar
Journal:  Int J Clin Pediatr Dent       Date:  2014-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.